A synthetic peptide from human microtubule-associated proteins 1A/1B light chain 3A (MAP1LC3A MAP1A/MAP1B LC3 A) conjugated to ablue carrier protein has been used as the antigen. The peptide is homologous in rat and mouse.
MAP1LC3A
Reactivity: Human
WB, IHC, IP
Host: Rabbit
Monoclonal
unconjugated
Application Notes
IHC WB. Use at a concentration of 10-50 μg,ml. The optimal workiing concentration should be determined by the end user. Not yet tested in other applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Reconstitute in 500 µL of sterile water. Centrifuge to remove any insoluble material.
Handling Advice
Avoid freeze and thaw cycles.
Storage
4 °C,-20 °C
Storage Comment
Maintain the lyophilised/reconstituted antibodies frozen at -20C for long term storage and refrigerated at 2-8C for a shorter term. When reconstituting glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Expiry Date
12 months
Target
MAP1LC3A
(Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))
Alternative Name
MAP1LC3A
Background
MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. The protein encoded by this gene is one of the light chain subunits and can associate with either MAP1A or MAP1B. Two transcript variants encoding different isoforms have been found for this gene. This protein is probably involved in formation of autophagosomal vacuoles. SUBCELLULAR LOCATION: Cytoplasm. Intracytoplasmic membrane, Lipid-anchor. Cytoplasmic vesicle autophagosome membrane, Lipid-anchor. Note: LC3-II binds to the autophagic membranes. TISSUE SPECIFICITY: Most abundant in heart brain liver skeletal muscle and testis but absent in thymus and peripheral blood leukocytes.